Lilly to acquire Massachusetts-based cell therapy firm for $2.4B

Please subscribe to IBJ to decode this article.

lapnlasc eeol oe nnaoh$a Mo acr ibnc.hiwatn gWct a’L sieeemtete iylcdtslrndndlb t,y uees te iyl strcvt4oa insaiiaCu spi teoc E eqsy -psh ionobsahgplas d eyheahcdOrto aoptcieognM.wini bnaya hrohri n etsTut pltthu ,tuldtoiianselntol.2ap dnaeeahpae

ogtihm tcC imo o icnitca aey,lEdt tsril 5tdpiedldrmeer t pat.wea i BsaTg-laee eer2lds,u 2gO9eaecAm uo apusn t csRrinei,cse eheuaor-sisia,ap-bsildeh oludspsOtcrrtt-cduBpmtilw- -eseryNtd ertflr uo etRlocn dn-hCd -eesaorwsl.maxs ps nsemladcntsn mteniDekcteh antird acrtegT ti1 i noe tae vhlin,laeraodise rr 1fenva’nyiaoTmeeaep,ri ar he

erflr tcwzr nonngo hieac pen,yt t a tft-h w ear y cd et.tcohytfrln nesosiaAlsb t hsrhemaerodiotiCnoanoacyiacctu -rch r eer ftbe somoerire i rdoiroacetid e valcahoatrlecAn p-gw oat anrc spotoarnetoc e rinareeC poodnno.Rpmcetnsoatl Aem’ep ftee gSTi es lnh t emnn

repeoh tvha,vciie J.oc rtaadse toei ;naidrigs“mpr lcn aSdled& a setbsk wewnnPrFeo dCry leyyia,esi;en ksBn;e,eGsNoMceiclCbfmerrtnee sn v aaJinoistyns BsnmgrNoeebe mreoiluu nraantch ieruwn sotie ad,o arbbhfoinswneosnmect n nf roo avcykster, ooJ hcgmoixba- t Jhbtatls”Cwis Nt nSlpsyn--veatitnrgpeeo- ail-d ecsea qdvlenhf

ev,toteveesietdetsivih“oslv ,rcA yprrr i on uit”nlac nthpHeoii pa scnio- atdOuml til iibipe r ercoRrad cde ienlndna w ao gsNhroeayrvnehtenbee,ehid ewnegrule gltwl e.n

enoutedeee sio lnriO vnps yet y t srtrtTjaeeruidaBnCrrolhseehatdxi te epLtseellEnllrsg dr, tie,oaJohf setoo "nOfemtniir eeoi p eta-eats”epfztaaeoci nt,r h helesdpfeWcuoe i oepl.lf ic ,naaelintiechro wishccul ia tn onace t

t elttlmm lamramnt i seeic ”ad ekt lp v eena pht re eetlnpgaDgtgernoua slezlooweolyhpshneRaoylncCdRa i aheslop swlnah ciFEttIyniino niíddonlednttcaaiilm ceal colasasflwn “ aeiltei.ntlaL ltitan sriimcersleouenw o ieeocosV- o rrfyestarmlmernes cd Hydfyt n voaoinrieoitcee

b wt sieexftTe íscgaerersila caa reitcelscre ee ipttsayr Aeoe oeocnht,ftu taebtighhaee-ona,hhlsRowtzsih,st aro eosrvtporbuaohiath gox dgteeiuuaavpseClvk aneallerrEd l lyehitpn Ven nem nudontdol ok hao m .hienoas“es oo mu aRsftdss lhy ” hol tmtpcisieopesoa - t  emtgmderdi s,spuii las ofeitl tnuwpaerhvr m opip

n enaed a iftltessidh areb rqmmdisnu innn ceOsstad-soynr itaeataaa ecidibt adiasrymf kfbrltndcp a.ha nblt bed osleli e ritoontIelyoo t eyibtL siaasiedit nrorsbi gslnoetotuldeysvstetse asntaeeTt

s pssssiD iegeyetahrl-hreheit"cl/ti/ttdbuthsytia>gbooroseah pnatl niasa ob-n-saw euenrenniirio m2irtiovliwAtbne loccidts alie=yhns/ofwlldn pnla gssarcdnelolci.orcnaeatt-1eorodfcwqs-nsohuea sfSon-pa oLsoas.atculnSt nii2od snadss t -aiflm:laare muold lttea-tp irgae p r-dawuec /lbtrawray.n a.etirhacaalcctnrelo,m"n,1nh j-u-a/fanraLboa hncaonyisupdltCnlcry mifd /nmsxisaesl r efaan-geb o o2-yoacgazdhmicgu/t-/Je-eeha-rnivn>abal-digeilivVe -slBx 'mbr1tDeeiuiiT -lVs1

aroirJuatp l".ni-v f conrptd -cue-iro3u-l sta>cgradpdirfhueihams/tbeaon pg ash/h.tat hemacg- qoiod-vyiLnm odnsnasifqrsc ey enjlBrsr<-sieddnyn/equed.o cs>t/"1islie-rdoet tnbefsliNaagraaupvml rRio/eaenhdraotae-vahaods btilb"uha1to-e.ri,qarwA liny puwdldf-vfes"c<$fc- a:q lnc c-i-eee:.la we/as uc oee rdlieb/deop fse seact/ecau,u godectyo3in tntcr.ite